Next Article in Journal
Neoadjuvant Therapy or Upfront Surgery for Pancreatic Cancer—To Whom, When, and How?
Next Article in Special Issue
Comparative Mechanistic Insights and Therapeutic Potential of Pembrolizumab, Durvalumab, and Ipilimumab as Immune Checkpoint Inhibitors in the Targeted Management of Oral and Head and Neck Squamous Cell Carcinoma
Previous Article in Journal
Therapeutic Cancer Vaccines in Colorectal Cancer: Platforms, Mechanisms, and Combinations
Previous Article in Special Issue
Future Perspectives in Senescence-Based Therapies for Head and Neck Cancer
 
 
Article

Article Versions Notes

Cancers 2025, 17(15), 2583; https://doi.org/10.3390/cancers17152583
Action Date Notes Link
article xml file uploaded 6 August 2025 10:38 CEST Original file -
article xml uploaded. 6 August 2025 10:38 CEST Update https://www.mdpi.com/2072-6694/17/15/2583/xml
article pdf uploaded. 6 August 2025 10:38 CEST Version of Record https://www.mdpi.com/2072-6694/17/15/2583/pdf
article supplementary file uploaded. 6 August 2025 10:38 CEST - https://www.mdpi.com/2072-6694/17/15/2583#supplementary
article html file updated 6 August 2025 10:41 CEST Original file -
article html file updated 28 August 2025 09:20 CEST Update -
article html file updated 15 September 2025 09:05 CEST Update https://www.mdpi.com/2072-6694/17/15/2583/html
Back to TopTop